Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 29, 2022
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
Benjamin Vesin, Jodie Lopez, Amandine Noirat, et al.
Scientific Reports
|
May 12, 2018
Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
Joana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
Scientific Reports
|
July 16, 2017
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
Joana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
EMBO Molecular Medicine
|
October 14, 2021
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice
Min-Wen Ku, Pierre Authié, Maryline Bourgine, et al.
Journal of Virology
|
April 2, 2024
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, et al.
Cell Host & Microbe
|
December 28, 2020
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
Min-Wen Ku, Maryline Bourgine, Pierre Authié, et al.
Applied and Environmental Microbiology
|
July 20, 2014
Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach
Maria H Daleke-Schermerhorn, Tristan Felix, Zora Soprova, et al.
Plos Pathogens
|
August 29, 2024
Marine sponge microbe provides insights into evolution and virulence of the tubercle bacillus
Sacha J Pidot, Stephan Klatt, Louis S Ates, et al.
ACS Nano
|
March 2, 2019
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis
Arnaud Machelart, Giuseppina Salzano, Xue Li, et al.
Nature Communications
|
December 30, 2025
Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1<sup>+</sup> cDC1 infiltration and activates anti-tumor immunity
Louise Gorline, Fillipe Luiz Rosa do Carmo, Pierre Bourdely, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 29, 2022
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
Benjamin Vesin, Jodie Lopez, Amandine Noirat, et al.
Scientific Reports
|
May 12, 2018
Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
Joana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
Scientific Reports
|
July 16, 2017
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
Joana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
EMBO Molecular Medicine
|
October 14, 2021
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice
Min-Wen Ku, Pierre Authié, Maryline Bourgine, et al.
Journal of Virology
|
April 2, 2024
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, et al.
Cell Host & Microbe
|
December 28, 2020
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
Min-Wen Ku, Maryline Bourgine, Pierre Authié, et al.
Applied and Environmental Microbiology
|
July 20, 2014
Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach
Maria H Daleke-Schermerhorn, Tristan Felix, Zora Soprova, et al.
Plos Pathogens
|
August 29, 2024
Marine sponge microbe provides insights into evolution and virulence of the tubercle bacillus
Sacha J Pidot, Stephan Klatt, Louis S Ates, et al.
ACS Nano
|
March 2, 2019
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis
Arnaud Machelart, Giuseppina Salzano, Xue Li, et al.
Nature Communications
|
December 30, 2025
Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1<sup>+</sup> cDC1 infiltration and activates anti-tumor immunity
Louise Gorline, Fillipe Luiz Rosa do Carmo, Pierre Bourdely, et al.
Page
of 8